BIOATLA, INC. Public Float
BIOATLA, INC. (BCAB) had Public Float of $18.70 million as of 2025-06-30, per its 10-K/A filed 2026-04-29.
Financial Statements › Notes
dei:EntityPublicFloat · last filed 2026-04-29
- 2025-06-30: Entity Public Float $18.70M.
- 2024-06-30: Entity Public Float $59.90M.
- 2023-06-30: Entity Public Float $91.00M.
- 2022-06-30: Entity Public Float $69.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $18.70M 10-K/A · filed 2026-04-29 |
| 2024-06-30 | $59.90M 10-K · filed 2025-03-28 |
| 2023-06-30 | $91.00M 10-K · filed 2024-03-26 |
| 2022-06-30 | $69.00M 10-K · filed 2023-03-23 |
| 2021-06-30 | $1.00B 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |